The Director General of the Nigeria Centre for Disease Control and Prevention, Dr. Ifedayo Adetifa, announced that the agency held an emergency meeting in Jigawa State to address the meningitis outbreak there. The Emergency Operations Centre convened to review the response, identify challenges, and propose solutions. Dr. Adetifa shared these details in a series of tweets on Saturday.
Meningitis is an inflammation of the meninges—the thin connective‑tissue layer covering the brain and spinal cord. When caused by infection, it can result from bacteria, viruses, parasites, or fungi; injuries and certain drugs may also trigger inflammation. Common signs and symptoms include fever, headache, nausea and vomiting, neck stiffness, and altered consciousness. The disease spreads person‑to‑person through respiratory or throat secretions.
The outbreak in Nigeria raises concerns about international spread, as a concurrent meningitis outbreak is occurring in Zinder State, Niger Republic, which shares a border with Jigawa. The World Health Organization (WHO) warns that simultaneous epidemics, insecurity, population displacement, and a protracted humanitarian crisis could facilitate further spread across West Africa. WHO assesses the risk from the Niger outbreak as high nationally, moderate regionally, and low globally.
During his visit, Dr. Adetifa met with the Jigawa State Government, the Rapid Response Team, and other partners to curb the disease’s spread. He praised the commitment of local health officials and collaborating organizations, including the Jigawa State Government’s SMOH, the NCDC Rapid Response Team, the National Primary Health Care Development Agency, WHO Nigeria, Médecins Sans Frontières Nigeria, and others. He emphasized that cross‑border surveillance and emergency preparedness plans must be continuous, noting that pathogens do not respect borders and that vaccination remains key to prevention.
From 1 November 2022 to 27 January 2023, Zinder Region reported 559 meningitis cases—111 laboratory‑confirmed—and 18 deaths. Meningitis carries a high case‑fatality rate and can cause serious long‑term complications. Preventing the disease through vaccination is the most effective strategy, providing long‑lasting protection. WHO stresses that rolling out multivalent meningococcal conjugate vaccines is a public‑health priority for eliminating bacterial meningitis epidemics in the African meningitis belt. Integrating these vaccines into routine immunisation programmes and maintaining high coverage are essential to prevent future epidemics.
Comments are closed for this story.